NYSE:CRLLife Sciences
Are Margin Pressures Shaping Charles River’s (CRL) Competitive Position Amid Stabilizing Revenue Guidance?
Charles River Laboratories International recently announced its second quarter 2025 results, reporting revenue of US$1.03 billion and net income of US$52.33 million, both nearly flat or lower compared to the previous year, and updated its full-year outlook to reflect a smaller projected revenue decline.
The company’s revised guidance, showing a softer fall in revenue and confirmation of earnings estimates, may indicate some stabilization in business conditions despite ongoing margin...
